AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06107569 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Antibiotic
Description: Antibiotics for Clostridioides infection (oral vancomycin) or association of intravenous metronidazol for severe cases.
Study NCT06567067 — intervention group
Intervention type: DEVICE
Intervention: Pulsenmore ES home ultrasound
Description: Fetal Ultrasound scanning using Pulsenmore ES device followed with an interview by a human factoring researched
Study NCT06091527 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Yoga practice
Description: 90-minute group yoga classes twice weekly for 12 weeks.
Study NCT06091527 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Education
Description: 90-minute group education classes twice weekly for 12 weeks to learn holistic healthcare modules.
Study NCT05444114 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Mental Exercise
Description: Participants perform a 10 minute mental exercise that is either mindful breathing or listening to a story
Study NCT05444114 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mental Exercise
Description: Participants perform a 10 minute mental exercise that is either mindful breathing or listening to a story
Study NCT04163328 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HydroEye®
Description: This is an omega-3 fatty acids supplement.
Study NCT04163328 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: HydroEye®
Description: This is an omega-3 fatty acids supplement.
Study NCT05967767 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Normobaric Hypoxia Exposure
Description: Hypoxia group were exposed to normobaric hypoxia equal to 3420 m (FiO2: 13.5-13.6 %).
Study NCT05967767 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Normobaric Normoxia Exposure
Description: Placebo group were exposed to normobaric normoxia equal to 162 m (FiO2: 20.9 %) through wearing the altitude generator mask.
Study NCT04857879 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: GLA:D program (Good Life with osteoArthritis in Denmark)
Description: GLA:D includes disease-specific education combined with neuromuscular exercises. Control interventions include disease-specific education combined with exercises to optimize movement and strength of the affected knee.
Study NCT04857879 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: GLA:D program (Good Life with osteoArthritis in Denmark)
Description: GLA:D includes disease-specific education combined with neuromuscular exercises. Control interventions include disease-specific education combined with exercises to optimize movement and strength of the affected knee.
Study NCT04686968 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Greenhouse Technique
Description: First, the high-strength sutures were passed through the teared tendon, and then Crimson duvet procedure was performed on the footprint from the articular margin of the humeral head to the apex of the greater tubercle, followed by a lateral row anchor.
Study NCT04686968 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Microfracture Combined With Suture Bridge Technique
Description: A three-line anchor suture method is used as in the greenhouse technique, except that the position is between the apex of the greater tubercle and the articular surface. After the rotator cuff is sutured, the bone bed beyond the suture point to the outer edge of the greater tubercle is opened with 2.0mm Kirschner wire every 5mm ( Crimson duvet), 1cm in depth, about 6 in total.
Study NCT06541691 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Enteric-coated aspirin
Description: Enteric-coated aspirin tablet 81 mg, once daily
Study NCT06541691 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Plain aspirin
Description: Plain aspirin tablet 81 mg, once daily
Study NCT06541691 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Hybrid strategy
Description: A hybrid strategy composed from:~* A one-page educational flashcard~* Alerting patients on highly polluted days via text message~* Encouraging patients to stay at home or minimizing outdoor activity on highly polluted days~* Encouraging patients via text message to wear KN-95 facemasks (provided by the investigators of this study) during outdoors time on highly polluted days~* Encouraging patients to consume citrus fruits during highly polluted days
Study NCT06341465 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Just Exercise
Description: Schroth exercises are including rotational breathing, correction techniques, positioning, mobilization, and three-dimensional exercises specific to their curvature.
Study NCT06341465 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise
Description: Schroth exercises are including rotational breathing, correction techniques, positioning, mobilization, and three-dimensional exercises specific to their curvature.
Study NCT06341465 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Taping
Description: Kinesiological taping will be applied as a tone enhancer or tone reducer according to the the concave and convex sides of the curve.
Study NCT06320470 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Educational Session
Description: The initial session will last about 45 to 60 minutes. The subsequent 3 sessions are anticipated to take about 20-30 minutes.
Study NCT06207279 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: rating
Description: rating scales, test ANT
Study NCT05288205 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JAB-21822
Description: KRAS G12C inhibitor
Study NCT05288205 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JAB-3312
Description: SHP2 inhibitor
Study NCT05755828 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: ASCT+CAR-T Cell Infusion
Description: CD19 CAR-T cells were prepared from peripheral lymphocytes of NHL patients with PR after 3 to 4 courses of chemotherapy, and autologous stem cells were collected and frozen after mobilization of patient stem cells by granulocyte stimulating factor (10μg/kg/d\*5d). BEAM pretreatment was performed. Autologous stem cells were injected 24 h after pretreatment, and the number of CD34+ cells was > 2\*106/kg. On the 6th day after transplantation, autologous Anti-CD19 CAR T cells were transfused, and the dose was determined by the investigator according to the subjects' own disease conditions and in vitro preparation. The patients were given constant intravenous drip/push infusion for 30 minutes.
Study NCT04403022 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Robotic Assisted Surgery
Description: da Vinci SP Surgical System, instruments, and accessories in complex colorectal procedures such as low anterior resection procedure or right colectomy with or without total mesorectal excision
Study NCT05238701 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LPM3770164 sustained release tablet
Description: LPM3770164 sustained release tablet will be administrated orally single-dose on day 1
Study NCT05238701 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: LPM3770164 sustained release tablet simulant
Description: LPM3770164 sustained release tablet simulant will be administrated orally single-dose on day 1
Study NCT05369221 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ReSpace™
Description: All of the subjects will be injected with ReSpace™ hydrogel.
Study NCT06455163 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Eerder Erbij
Description: The intervention (Eerder Erbij, EE) is a person-centred, manual-based intervention consisting of education, information and a support group for persons in the early stage of dementia and their main informal caregiver (e.g. spouse, relative), who receive little or no formal care. The intervention will discuss the effects of dementia, and how to cope and adjust to those effects. It will take place in small group sessions led by a health care professional (e.g. casemanager) and is intended for both the person with dementia and the caregiver. The intervention will be personalised to meet needs, interests and strengths of the dyad by discussing the sessions content at the start of the intervention.
Study NCT05168007 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: WID-RGC20(Cariprazine) 3mg/day
Description: The initial dose is WID-RGC20(Cariprazine) 1.5mg/day, followed by an up-titration of 1.5mg/day until the target dose(3mg/day) is achieved. The investigational product is administered during the double-blind treatment period(6 weeks).
Study NCT05168007 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: WID-RGC20(Cariprazine) 6mg/day
Description: The initial dose is WID-RGC20(Cariprazine) 1.5mg/day, followed by an up-titration of 1.5mg/day until the target dose(6mg/day) is achieved. The investigational product is administered during the double-blind treatment period(6 weeks).
Study NCT05168007 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo for WID-RGC20(Cariprazine) 3mg/day or 6mg/day
Description: The placebo comparator is administered during the double-blind treatment period(6 weeks).
Study NCT05924035 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: HBOT
Description: HBOT treatment on a multiplace chamber (OXYHeal Hyperbaric Oxygen Chamber), 100% oxygen at 2.0 atmospheres for 90 minutes - on 4 consecutive days within 3 hours of completion of exercise training (as soon as practically possible). This will occur during week 2 of data collection.
Study NCT05521204 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Olverembatinib
Description: Given PO
Study NCT05411848 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: 2kcal HP PlantBased
Description: Patients will receive a minimum of 1 bottle per day of either (or both of) 2kcal HP PlantBased and/or 2kcal HP PlantBased MultiFibre Tube Feeds for a minimum of 7 days and a maximum of 28 days. During the 12-month follow-up, patients will have access to the same trial prescription as per the 28-day intervention period.
Study NCT05355194 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Kinesiotape
Description: Patients will be instructed to inhale while taping the application. The tape will be applied in a vertical direction from just below the navel to the pubic region, another tape will be applied over the initial tape in the horizontal direction with minimal stretch. Another tape will be applied over the lumbosacral region making a V shape. The arms of V shall lie over the lumbar region while the base shall rest over the caudal region. Taping will be maintained for at least 48 hours.~The interventions shall be applied for two consecutive menstrual cycles.
Study NCT05355194 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Kinesiotape
Description: Patients will be instructed to inhale while taping the application. The tape will be applied in a vertical direction from just below the navel to the pubic region, another tape will be applied over the initial tape in the horizontal direction with minimal stretch. Another tape will be applied over the lumbosacral region making a V shape. The arms of V shall lie over the lumbar region while the base shall rest over the caudal region. Taping will be maintained for at least 48 hours.~The interventions shall be applied for two consecutive menstrual cycles.
Study NCT05355194 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pelvic Tilts
Description: Patients will be asked to lie in a supine position with legs bent and toes facing forward. Afterward, they will be instructed to pull their belly inwards while pushing pelvis towards the ceiling and keep hip muscles tightened. This position will be maintained for 5 seconds with 3 sets of 20 repetitions. Pelvic tilts must be performed throughout the menstrual cycle.
Study NCT04960228 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Altruism Video
Description: The video provides three vignettes about a diverse set of people who may be more vulnerable to serious health consequences from COVID-19. In each of the stories, high vaccine uptake of those around these vulnerable individuals serves to protect them. This communicates that getting the COVID-19 vaccine can be done for prosocial reasons and to foster a sense of community, as it provides protection not only to oneself, but also to others.
Study NCT04960228 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: COVID-19 Informational Text
Description: The topics included in the text are how COVID-19 spreads, hygiene, physical distancing, and travel restrictions. Participants will complete three comprehension questions, one after each of the following sections: hygiene, physical distancing, and travel restrictions.
Study NCT05411510 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Densah bur
Description: Surgical treatment
Study NCT05411510 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Densah bur
Description: Surgical treatment
Study NCT04955106 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: SEM Scanner
Description: They will perform 2 sets of 3 measures (1 on sacrum, 1 on the right heel and 1 on the left heel)for each patients
Study NCT05546333 — intervention group
Intervention type: DEVICE
Intervention: Electrical impedance tomography
Description: Non-invasive measure of electrical impedance in the body, with data collected on electrodes on the surface of the body
Study NCT06274554 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fluconazole
Description: Oral fluconazole capsules.
Study NCT06274554 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Oral placebo capsules will be used as a comparator.
Study NCT06274554 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: IL-23 Therapy
Description: Risankizumab (IL-23) or Ustekinumab (IL-12/23) as standard of care treatment.
Study NCT06274554 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: IL-23 Therapy
Description: Risankizumab (IL-23) or Ustekinumab (IL-12/23) as standard of care treatment.
Study NCT05281731 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sonobiopsy
Description: Ultrasound combined with microbubbles to facilitate sampling of biomarkers from brain tumors via blood-based liquid biopsy
Study NCT05281731 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Research blood
Description: No more than 10 minutes prior to ultrasound sonication, 10 minutes after ultrasound sonication, 30 minutes after ultrasound sonication (optional at the discretion of the PI), and 60 minutes after ultrasound sonication (optional at the discretion of the PI)
Study NCT05281731 — intervention group
Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: Cancer Personalized Profiling
Description: Cancer Personalized Profiling by deep Sequencing will be used to compare the frequency of tumor-specific variants in the blood before and after sonobiopsy.
Study NCT05281731 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Definity®
Description: Being used off-label in this trial
Study NCT04617093 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: PrismaLung+
Description: Overall, up to 60 adult patients will be initiated on ECCO2R using PrismaLung+. A minimum of approximately 15 patients will be treated with ECCO2R using PrismaLung+ as stand-alone therapy and another minimum of approximately 15 patients (maximum of 20) will receive ECCO2R using PrismaLung+ in combination with CRRT.
Study NCT05009797 — intervention group
Intervention type: PROCEDURE
Intervention: atrial fibrillation catheter ablation
Description: The ablation is performed under local anesthesia or general anesthesia. A transseptal puncture will be performed to access the left atrium. Pulmonary vein isolation will be performed as a first step. Additional lesions will be made at the discretion of the operators. Patients will receive anticoagulation for at least 3 months after the ablation. Treatment thereafter will be extended at the discretion of the treating physician.
Study NCT05033964 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Percutaneous Coronary Intervention with drug eluting stents
Description: Coronary drug eluting stent implantation
Study NCT05033964 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: Percutaneous Coronary Intervention with drug eluting stents
Description: Coronary drug eluting stent implantation
Study NCT04943510 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Physical exercices
Description: surface EMG: surface electrodes will be positioned on the muscles to evaluate the level of muscle activation~non invasive muscular neurostimulations : application of a percutaneous electrical stimulation of the motor nerve of the considered muscle and a direct electrical stimulation of the muscle
Study NCT06390020 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: MBSR
Description: The MBSR training spans eight weeks and follows a standardized protocol. It consists of eight weekly sessions, each lasting 2.5 hours, a single 6-hour silent day, and daily home exercises. Additionally, the program incorporates personalized psychoeducation on high sensory processing sensitivity, covering its characteristics, scientific foundations, its relation with stress-related symptoms, and why mindfulness might be helpful.
Study NCT05035771 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Pressure wire measurement in peripheral vascular disease
Description: The aim of IMPACT PAD is to examine the safety and feasibility of intraprocedural flow, pressure and resistance rate changes to help predict the success of a peripheral endovascular intervention.
Study NCT06205927 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Standard carbon ion beam radiotherapy
Description: The standard treatment arm will receive carbon ion beam radiotherapy of 77Gy (RBE equivalent) per 22 fractions for gross tumor volume.
Study NCT06205927 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Carbon ion beam radiotherapy simultaneously dose boost
Description: The hypoxic lesions dose boost arm will receive 77Gy (RBE equivalent) per 22 fractions for gross tumor volume and a simultaneously dose boost of 83.6Gy (RBE equivalent) per 22 fractions for hypoxic lesions detected by 18F-Misonidazole PET/CT.
Study NCT04971031 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Reproxalap Ophthalmic Solution (0.25%)
Description: Reproxalap Ophthalmic Solution (0.25%) administered 7 times over two consecutive days.
Study NCT04971031 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Vehicle Ophthalmic Solution
Description: Vehicle Ophthalmic Solution administered 7 times over two consecutive days.
Study NCT05395819 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Reverse Total Shoulder Arthroplasty (RTSA)
Description: Patient will undergo a RTSA as per standard technique. It uses a stemmed metal humeral component attached to the glenoid and the shallow glenoid component attached to the humerus. Pre-operative CT imaging and surgical planning software based on pre-operative CT scans will be used in each case to determine the degree of eccentric (high side) anterior reaming to within \< 10 degrees of neutral glenoid version. Standard instruments including a spherical burr and power reamers will be used to achieve this.
Study NCT05395819 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Total Shoulder Arthroplasty (TSA)
Description: Patients will undergo standard glenoid preparation and implantation of a TSA. It uses a stemmed metal humeral component to replace the arthritic head of humerus and a shallow polyethylene glenoid component to replace the arthritic glenoid surface. The degree of anterior- reaming will be based on pre-operative CT scan assessment and templating software with the goal of correcting glenoid retroversion to within 10 degrees of neutral version.
Study NCT05137795 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ZYESAMI™ (aviptadil acetate)
Description: Inhaled ZYESAMI™ (aviptadil acetate) 100μg 3x daily by mesh nebulizer
Study NCT05137795 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Normal Saline Inhalation
Study NCT05137795 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Nebulized administration of ZYESAMI™ or Placebo
Description: Use of 510(k) cleared mesh nebulizer to deliver investigational product
Study NCT04917406 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Application of lidocaine together with dexamethasone
Description: Lidocaine 2% is applied on the positive pole while dexamethasone 4 mg/ml is applied on the negative pole. Through the use of current the drugs penetrate the fascia.
Study NCT05620290 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Definity
Description: Stimulation of Definity microbubbles using Sonalleve device within tumour vasculature
Study NCT05620290 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sonalleve Focused Ultrasound Device
Description: Sonalleve Focused Ultrasound Device
Study NCT04917406 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Application of ultrasound as physical therapy
Description: The application dose will be 0.65 Watt for 7 minutes in the area of most painful affectation by means of a circular movement and a 1MZ head.
Study NCT05664035 — intervention group
Intervention type: BIOLOGICAL
Intervention: Diagnosis of SPAD using immunization with PPV23
Description: Diagnosis of SPAD using immunization with PPV23
Study NCT05989243 — intervention group
Intervention type: DEVICE
Intervention: Conventional prosthetic socket
Description: Participants will use their own conventional rigid socket and will be asked to walk on a force-measuring treadmill on level ground at 0.75, 1.0, 1.25, and 1.5 m/s for \~60 sec per speed. They will also be asked to evaluate this socket using a questionnaire.